Treatment of Pulmonary Anthrax in Adults Aged 18 and Older: Systemic Anthrax (Not Pregnant, Not Lactating)
Systemic anthrax arising from inhalation exposure — pulmonary anthrax — requires prompt, protocol-driven antimicrobial management. The appropriate regimen in non-pregnant, non-lactating adults depends critically on suspected meningeal involvement and which drug classes are tolerated and available.
References
For nonpregnant adults aged ≥18 years with systemic anthrax with or without meningitis, bactericidal agents have been found to provide a survival benefit compared with other agents and are preferred over PSIs (Table 8).
If an appropriate combination of bactericidal antimicrobial drug plus a PSI or an RNAI is contraindicated, not well tolerated, or not available or if meningitis is considered unlikely, consider the following regimens in descending order of preference: One bactericidal drug plus a PSI (start with this regimen if meningitis is not suspected and susceptibilities are known); One bactericidal drug plus a second bactericidal drug from a different antimicrobial drug class; One bactericidal drug plus an RNAI; A PSI plus an RNAI; Two PSIs from different antimicrobial drug classes; A single bactericidal drug; A single PSI.
View source ↗